According to the US National Cancer Institute (NCI), approximately 760,000 cases of stomach cancer are diagnosed worldwide and it is the second leading cause of cancer-related deaths.
Thanks to its excellent multidisciplinary treatments, NUH has managed to improve the survival rates of its gastric cancer patients. The proportion of patients with high-risk stomach cancer (Stage II-IV) who are alive at 2 years after surgery and chemo-radiotherapy in NUH is 69.4%. This fares well against the 60.0% reported by the US Intergroup 0116 Study and 40.5% in an Australian multicentre study report. |
